• 1
    Singh N, Paterson DL. Mycobacterium tuberculosis infection in solid-organ transplant recipients: Impact and implications for management. Clin Infect Dis 1998; 27: 12661277.
  • 2
    Queipo JA, Broseta E, Santos M, Sanchez-Plumed J, Budia A, Jimenez-Cruz F. Mycobacterial infection in a series of 1261 renal transplant recipients. Clin Microbiol Infect 2003; 9: 518525.
  • 3
    Munoz P, Rodriguez C, Bouza E. Mycobacterium tuberculosis infection in recipients of solid organ transplants. Clin Infect Dis 2005; 40: 581587.
  • 4
    Morales P, Briones A, Torres JJ, Sole A, Perez D, Pastor A. Pulmonary tuberculosis in lung and heart-lung transplantation: Fifteen years of experience in a single center in Spain. Transplant Proc 2005; 37: 40504055.
  • 5
    Clemente WT, Faria LC, Lima SS, Vilela EG, Lima AS, Velloso LF, et al. Tuberculosis in liver transplant recipients: A single Brazilian center experience. Transplantation 2009; 87: 397401.
  • 6
    Subramanian A, Dorman S. Mycobacterium tuberculosis in solid organ transplant recipients. Am J Transplant 2009; 9(Suppl 4): S57S62.
  • 7
    Aguado JM, Torre-Cisneros J, Fortun J, et al. Tuberculosis in solid-organ transplant recipients: Consensus statement of the group for the study of infection in transplant recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology. Clin Infect Dis 2009; 48: 12761284.
  • 8
    Transplantation-transmitted tuberculosis—Oklahoma and Texas, 2007. MMWR 2008; 57: 333336.
  • 9
    John GT, Shankar V. Mycobacterial infections in organ transplant recipients. Semin Respir Infect 2002; 17: 274283.
  • 10
    Ison MG, Nalesnik MA. An update on donor-derived disease transmission in organ transplantation. Am J Transplant 2011; 11: 11231130.
  • 11
    Kumar D, Humar A. Tuberculosis and transplantation: Battling the opportunist. Clin Infect Dis 2009; 48: 16661668.
  • 12
    Winthrop KL, Kubak BM, Pegues DA, et al. Transmission of mycobacterium tuberculosis via lung transplantation. Am J Transplant 2004; 4: 15291533.
  • 13
    Ison MG, Hager J, Blumberg E, et al. Donor-derived disease transmission events in the United States: Data reviewed by the OPTN/UNOS Disease Transmission Advisory Committee. Am J Transplant 2009; 9: 19291935.
  • 14
    Trends in tuberculosis—United States, 2010. MMWR 2011; 60: 333337.
  • 15
    Sester M, Sotgiu G, Lange C, et al. Interferon-γ release assays for the diagnosis of active tuberculosis: A systematic review and meta-analysis. Eur Respir J 2011; 37: 100111.
  • 16
    Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008; 149: 177184.
  • 17
    Mack U, Migliori GB, Sester M, et al. LTBI: Latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J 2009; 33: 956973.
  • 18
    Sester U, Wilkens H, van Bentum K, et al. Impaired detection of Mycobacterium tuberculosis immunity in patients using high levels of immunosuppressive drugs. Eur Respir J 2009; 34: 702710.
  • 19
    Diel R, Loddenkemper R, Meywald-Walter K, Niemann S, Nienhaus A. Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. Am J Respir Crit Care Med 2008; 177: 11641170.
  • 20
    Aichelburg MC, Rieger A, Breitenecker F, et al. Detection and prediction of active tuberculosis disease by a whole-blood interferon-gamma release assay in HIV-1-infected individuals. Clin Infect Dis 2009; 48: 954962.
  • 21
    Diel R, Goletti D, Ferrara G, et al. Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection: Asystematic review and meta-analysis. Eur Respir J 2011; 37: 8899.
  • 22
    Mancuso JD, Mazurek GH, Tribble D, et al. Discordance among Commercially Available Diagnostics for Latent Tuberculosis Infection. Am J Respir Crit Care Med 2012; 185: 427434.
  • 23
    Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K. Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection – United States, 2010. MMWR 2010; 59: 125.
  • 24
    Cho OH, Park KH, Kim SM, et al. Diagnostic performance of T-SPOT.TB for extrapulmonary tuberculosis according to the site of infection. J Infect 2011; 63: 362369.
  • 25
    Nunn AJ, Phillips PP, Mitchison DA. Timing of relapse in short-course chemotherapy trials for tuberculosis. Int J Tuberc Lung Dis 2010; 14: 241242.
  • 26
    OPTN. 4.0: Identification of transmissible diseases in organ recipients. 2010 Available at: Accessed July 15, 2011.
  • 27
    Agarwal SK, Gupta S, Dash SC, Bhowmik D, Tiwari SC. Prospective randomised trial of isoniazid prophylaxis in renal transplant recipient. Int Urol Nephrol 2004; 36: 425431.
  • 28
    John GT, Shankar V, Abraham AM, Mukundan U, Thomas PP, Jacob CK. Risk factors for post-transplant tuberculosis. Kidney Int 2001; 60: 11481153.
  • 29
    John GT, Thomas PP, Thomas M, Jeyaseelan L, Jacob CK, Shastry JC. A double-blind randomized controlled trial of primary isoniazid prophylaxis in dialysis and transplant patients. Transplantation 1994; 57: 16831684.
  • 30
    Treatment of tuberculosis. MMWR 2003; 52: 177.
  • 31
    Torre-Cisneros J, Caston JJ, Moreno J, et al. Tuberculosis in the transplant candidate: Importance of early diagnosis and treatment. Transplantation 2004; 77: 13761380.
  • 32
    Currie AC, Knight SR, Morris PJ. Tuberculosis in renal transplant recipients: The evidence for prophylaxis. Transplantation 2010; 90: 695704.
  • 33
    Trends in tuberculosis—United States, 2008. MMWR 2009; 58: 249253.
  • 34
    Dorman SE. Coming-of-age of nucleic acid amplification tests for the diagnosis of tuberculosis. Clin Infect Dis 2009; 49: 5557.
  • 35
    Laraque F, Griggs A, Slopen M, Munsiff SS. Performance of nucleic acid amplification tests for diagnosis of tuberculosis in a large urban setting. Clin Infect Dis 2009; 49: 4654.
  • 36
    Boddie DE, Currie DG, Eremin O, Heys SD. Immune suppression and isolated severe head injury: A significant clinical problem. Br J Neurosurg 2003; 17: 405417.
  • 37
    Meert KL, Long M, Kaplan J, Sarnaik AP. Alterations in immune function following head injury in children. Crit Care Med 1995; 23: 822828.
  • 38
    Bergamini BM, Losi M, Vaienti F, et al. Performance of commercial blood tests for the diagnosis of latent tuberculosis infection in children and adolescents. Pediatrics 2009; 123: e419e424.
  • 39
    Detjen AK, Keil T, Roll S, et al. Interferon-gamma release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis. Clin Infect Dis 2007; 45: 322328.
  • 40
    Torre-Cisneros J, Doblas A, Aguado JM, et al. Tuberculosis after solid-organ transplant: Incidence, risk factors, and clinical characteristics in the RESITRA (Spanish Network of Infection in Transplantation) cohort. Clin Infect Dis 2009; 48: 16571665.
  • 41
    Organization WH. Global tuberculosis control 2010. 2010 Available at: Accessed November 1, 2011.
  • 42
    Huebner RE, Schein MF, Bass JB, Jr. The tuberculin skin test. Clin Infect Dis 1993; 17: 968975.
  • 43
    Diel R, Loddenkemper R, Nienhaus A. Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: A metaanalysis. Chest 2010; 137: 952968.